跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BETA - NICARDIA CAPSULE - HSA Drug Approval Details
Approvals
/
HSA
/
BETA - NICARDIA CAPSULE
Approved
THERAPEUTIC
BETA - NICARDIA CAPSULE
UNIQUE PHARMACEUTICALS LABORATORIES (A DIV OF J B CHEMICALS & PHARM LTD) (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Aug 14, 2003
Approval ID
3fa9cf54df7675c4
Company
UNIQUE PHARMACEUTICALS LABORATORIES (A DIV OF J B CHEMICALS & PHARM LTD) (INDIA)
Type
Therapeutic
Approval Details
Approval Id
3fa9cf54df7675c4
Drug Name
BETA - NICARDIA CAPSULE
Product Name
BETA - NICARDIA CAPSULE
Approval Number
SIN12389P
Approval Date
2003-08-14
Registrant
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
C08CA55
Atc Item Name
nifedipine, combinations
Pharma Manufacturer Name
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Company Detail Path
/organization/singapore-pharmaceutical-private-limited
Active Ingredients
NIFEDIPINE
20 mg
ATENOLOL
50 mg
ATENOLOL
50 MG
NIFEDIPINE
20 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 14, 2003
Approval ID
3fa9cf54df7675c4
Type
Therapeutic
Back to HSA Approvals